Abstract
The present research work was aimed to design the transdermal delivery system of naproxen using Aloe vera as aqueous gel base. Aloe vera would able to potentiate the anti-inflammatory effect and also act as penetration enhancer. Carbopol 934 was used as a gelling agent. The prepared gel was assessed for pH, permeation parameters, drug content, skin irritation and in-vitro diffusion. Accelerated stability study was also carried out. In-vivo studies were performed to characterize the efficacy of the prepared naproxen-Aloe vera transgel (NAG). The pH of formulation was found to be 6.98. The values of permeation data for flux, permeability coefficient and enhancement ratio were obtained as 0.00907 µg cm-2 h-1, 0.00453 cm h-1 and 5.96 respectively. The viscosity was found as 610 cps for NAG. The drug release kinetics followed Higuchi model. Stability study has proved the integrity of the formulation. No skin irritation was observed in Wistar albino rats. Anti-inflammatory assessment in Wistar rats showed significant effect in paw-volume reduction at p<0.05 in less than one hour for NAG compared to that of plain Aloe gel and commercial naproxen gel (CNG). The prepared naproxen-Aloe gel (NAG) could able to show better anti-inflammatory activity compared to the CNG. This could be attributed by synergistic effect of Aloe.
Keywords: Diffusion, flux, paw edema, percent inhibition, permeability enhancement.
Drug Delivery Letters
Title:Pharmaceutical and Pharmacodynamic Evaluation of Naproxen Incorporated Aloe vera Transgel
Volume: 4 Issue: 2
Author(s): Thushara B. Dudala, Prasanna R. Yalavarthi, Rao P. Satyanarayana, Haritha Kodavatikanti, K.R. Vandana, Vinesha Velam and Harini C. Vadlamudi
Affiliation:
Keywords: Diffusion, flux, paw edema, percent inhibition, permeability enhancement.
Abstract: The present research work was aimed to design the transdermal delivery system of naproxen using Aloe vera as aqueous gel base. Aloe vera would able to potentiate the anti-inflammatory effect and also act as penetration enhancer. Carbopol 934 was used as a gelling agent. The prepared gel was assessed for pH, permeation parameters, drug content, skin irritation and in-vitro diffusion. Accelerated stability study was also carried out. In-vivo studies were performed to characterize the efficacy of the prepared naproxen-Aloe vera transgel (NAG). The pH of formulation was found to be 6.98. The values of permeation data for flux, permeability coefficient and enhancement ratio were obtained as 0.00907 µg cm-2 h-1, 0.00453 cm h-1 and 5.96 respectively. The viscosity was found as 610 cps for NAG. The drug release kinetics followed Higuchi model. Stability study has proved the integrity of the formulation. No skin irritation was observed in Wistar albino rats. Anti-inflammatory assessment in Wistar rats showed significant effect in paw-volume reduction at p<0.05 in less than one hour for NAG compared to that of plain Aloe gel and commercial naproxen gel (CNG). The prepared naproxen-Aloe gel (NAG) could able to show better anti-inflammatory activity compared to the CNG. This could be attributed by synergistic effect of Aloe.
Export Options
About this article
Cite this article as:
B. Dudala Thushara, R. Yalavarthi Prasanna, P. Satyanarayana Rao, Kodavatikanti Haritha, Vandana K.R., Velam Vinesha and C. Vadlamudi Harini, Pharmaceutical and Pharmacodynamic Evaluation of Naproxen Incorporated Aloe vera Transgel, Drug Delivery Letters 2014; 4 (2) . https://dx.doi.org/10.2174/22103031113039990012
DOI https://dx.doi.org/10.2174/22103031113039990012 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Proteins: A to Z
Protein & Peptide Letters Plant Proteinases and Inhibitors: An Overview of Biological Function and Pharmacological Activity
Current Protein & Peptide Science ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents
Current Medicinal Chemistry Stem Cells in Brain Tumorigenesis and their Impact on Therapy
Current Stem Cell Research & Therapy Emerging Immunotargets in Metastatic Renal Cell Carcinoma
Current Drug Targets Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)
Current Drug Targets Mitochondrial Dysfunction and Its Relationship with mTOR Signaling and Oxidative Damage in Autism Spectrum Disorders
Mini-Reviews in Medicinal Chemistry Recent Patents on Proteases and Kinases as Anti-Infective Agents: A Review
Recent Patents on Anti-Infective Drug Discovery Development of Calixarenes, Cyclodextrins and Fullerenes as New Platforms for Anti-HIV Drug Design: An Overview
Mini-Reviews in Medicinal Chemistry Modeling Study of Phenylsulfonylfuroxan Derivatives as P-gp Inhibitors: A Combined Approach of CoMFA, CoMSIA and HQSAR
Anti-Cancer Agents in Medicinal Chemistry Autophagy in Diabetic Retinopathy
Current Neuropharmacology Anti-angiogenic Treatment in Metastatic Colorectal Cancer: Current Issues and Future Aims
Current Cancer Therapy Reviews MicroRNAs in Glioblastoma: Role in Pathogenesis and Opportunities for Targeted Therapies
CNS & Neurological Disorders - Drug Targets Pulmonary Infections in the Era of Biological Agents
Current Respiratory Medicine Reviews Potential Therapeutic Applications of miRNA-Based Technology in Hematological Malignancies
Current Pharmaceutical Design Repositioning of DHFR Inhibitors
Current Topics in Medicinal Chemistry Imaging Methods in Gene Therapy of Cancer
Current Gene Therapy Double-Faced Role of Human Mesenchymal Stem Cells and their Role/Challenges in Cancer Therapy
Current Stem Cell Research & Therapy The N-Terminal Region of HIV-1 Tat Protein Binds CD127 in Human CD8 T Cells to Target the Receptor for Down Regulation Through Tat's Basic Region
Current HIV Research Natural Endoperoxides as Drug Lead Compounds
Current Medicinal Chemistry